Introduction. Heart failure (HF) is highly prevalent in patients with chronic kidney disease
(CKD) and end‐stage renal disease (ESRD) and is strongly associated with mortality in …

Background: Arterial stiffness determined by brachial–ankle pulse wave velocity (baPWV)
has been established as a powerful predictor of cardiovascular mortality in hemodialysis …

In end-stage renal disease (ESRD) patients, congestive heart failure (CHF) is a dreadful
complication. Its pathogenesis is multifactorial. Chronic arterial hypertension, uraemic …

Background: Hypertension is a leading cause of kidney failure, affects most dialysis patients
and associates with adverse outcomes. Hypertension can be difficult to control with dialysis …

The number of patients with end-stage renal disease (ESRD) has rapidly increased, as has
the cost of dialysis. Peritoneal dialysis (PD) is an established treatment for ESRD patients …

Background Patients with chronic kidney disease (CKD), end-stage renal disease (ESRD)
with dialysis, and kidney transplant (KT) recipients are associated with increased …

The use of peritoneal dialysis (PD) in end-stage renal disease is a well-known renal
replacement modality now. The interest in using PD for ESRD has been increasing over the …

Heart failure (HF) occurs in more than one third of patients with end stage renal disease
(ESRD) at the initiation of dialysis. Heart failure alone is an independent predictor of poor …

In end-stage renal disease (ESRD) patients, congestive heart failure (CHF) is a dreadful
complication. Its pathogenesis is multifactorial. Chronic arterial hypertension, uraemic …

Hypertension is common in chronic kidney diseases. The study was done in a six month
period. Totally 77 dialysis cases including 39 (50.6%) peritoneal dialysis and 38 (49.4%) …